These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9294120)

  • 1. Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance.
    Terzi F; Henrion D; Colucci-Guyon E; Federici P; Babinet C; Levy BI; Briand P; Friedlander G
    J Clin Invest; 1997 Sep; 100(6):1520-8. PubMed ID: 9294120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin.
    Henrion D; Terzi F; Matrougui K; Duriez M; Boulanger CM; Colucci-Guyon E; Babinet C; Briand P; Friedlander G; Poitevin P; Lévy BI
    J Clin Invest; 1997 Dec; 100(11):2909-14. PubMed ID: 9389758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
    Richard V; Solans V; Favre J; Henry JP; Lallemand F; Thuillez C; Marie I
    Fundam Clin Pharmacol; 2008 Dec; 22(6):649-55. PubMed ID: 19049669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin.
    Terzi F; Maunoury R; Colucci-Guyon E; Babinet C; Federici P; Briand P; Friedlander G
    Am J Pathol; 1997 Apr; 150(4):1361-71. PubMed ID: 9094992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endothelin in FK506-induced vascular reactivity changes in rat perfused kidney.
    Tekes E; Soydan G; Tuncer M
    Eur J Pharmacol; 2005 Jul; 517(1-2):92-6. PubMed ID: 15964565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased contribution of L-arginine-nitric oxide pathway in aorta of mice lacking the gene for vimentin.
    Zhang J; Henrion D; Ebrahimian T; Benessiano J; Colucci-Guyon E; Langa F; Lévy BI; Boulanger CM
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):552-60. PubMed ID: 11588525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise.
    Maeda S; Miyauchi T; Iemitsu M; Tanabe T; Goto K; Yamaguchi I; Matsuda M
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E609-14. PubMed ID: 14665447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males.
    Kimura M; Sudhir K; Jones M; Simpson E; Jefferis AM; Chin-Dusting JP
    Circ Res; 2003 Dec; 93(12):1267-71. PubMed ID: 14576203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant erythropoietin alters the flow-dependent vasodilatation of in vitro perfused rat mesenteric arteries with unbalanced endothelial endothelin-1 / nitric oxide ratio.
    Barhoumi T; Jallat I; Berthelot A; Laurant P
    Can J Physiol Pharmacol; 2011 Jun; 89(6):435-43. PubMed ID: 21777087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat.
    Champion HC; Estrada LS; Estrada LN; Filep JG; Kadowitz PJ
    Can J Physiol Pharmacol; 1998 Feb; 76(2):141-7. PubMed ID: 9635152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of endothelin-induced venoconstriction in isolated guinea pig mesentery.
    Johnson RJ; Fink GD; Galligan JJ
    J Pharmacol Exp Ther; 1999 May; 289(2):762-7. PubMed ID: 10215650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide.
    Traupe T; Nett PC; Frank B; Tornillo L; Hofmann-Lehmann R; Terracciano LM; Barton M
    Eur J Pharmacol; 2007 Feb; 557(2-3):161-7. PubMed ID: 17182032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
    Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
    Papadopoulos P; Ongali B; Hamel E
    Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice.
    Chataigneau T; Félétou M; Huang PL; Fishman MC; Duhault J; Vanhoutte PM
    Br J Pharmacol; 1999 Jan; 126(1):219-26. PubMed ID: 10051139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
    Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide and prostaglandin systems in lithium modulation of acetylcholine vasodilation.
    Rahimzadeh-Rofouyi B; Afsharimani B; Moezi L; Ebrahimi F; Mehr SE; Mombeini T; Ghahremani MH; Dehpour AR
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):641-6. PubMed ID: 18091580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
    Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
    J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats.
    Luo L; Dai DZ; Cheng YS; Zhang Q; Yuan WJ; Dai Y
    J Pharm Pharmacol; 2011 Jul; 63(7):943-51. PubMed ID: 21635260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.